Third Harmonic Bio (THRD) Announces Stockholder Approval of Plan of Liquidation and Dissolution Jun 12, 2025 08:02AM
Raymond James Reiterates Market Perform Rating on Third Harmonic Bio (THRD) Apr 14, 2025 09:09AM
Third Harmonic Bio (THRD) Announces Plan of Liquidation and Dissolution Apr 14, 2025 06:46AM
Stifel Downgrades Third Harmonic Bio (THRD) to Hold Mar 27, 2025 04:50PM
Morgan Stanley Downgrades Third Harmonic Bio (THRD) to Equalweight Feb 11, 2025 04:10PM


Feb 11, 2025 10:58AM Raymond James Downgrades Third Harmonic Bio (THRD) to Market Perform
Feb 11, 2025 07:00AM Third Harmonic Bio (THRD) Announces Phase 1 Clinical Results for THB335, Provides Corporate Strategic Update
Jan 14, 2025 12:45PM Third Harmonic Bio (THRD) PT Lowered to $7 at Jefferies
Jan 8, 2025 12:03PM Stifel on Celldex (CLDX) and Third Harmonic Bio (THRD): 'we continue to like the prospects of CLDX and THRD as both first-in-class and an oral pure-play'
Nov 7, 2024 01:23PM Stifel Reiterates Buy Rating on Third Harmonic Bio (THRD)
Aug 9, 2024 04:53AM Morgan Stanley Upgrades Third Harmonic Bio (THRD) to Overweight
Jun 17, 2024 04:08PM Stifel Starts Third Harmonic Bio (THRD) at Buy